Conference Interviews

Researchers from around the world gathered at the 2017 San Antonio Breast Cancer Symposium to present research that would change the way we view breast cancer.

At the 2018 Best of SABCS-NY, Sheldon Feldman, MD, FACS, chief of breast surgery and breast surgical oncology, Montefiore-Einstein Cancer Center, New York, director of breast...

At the 2018 Best of San Antonio Breast Cancer Symposium-New York, Joseph Sparano, MD, professor of medicine and women’s health, Albert Einstein College of Medicine,...

In clinical trials for cancer drug development, researchers have been enrolling patients who are otherwise healthy; patients who are asymptomatic, and have free mobility. By...

There are several factors that put female patients at an increased risk for breast cancer.

Amy C. Degnim, MD, professor of surgery, Mayo Clinic, Rochester, MN, discusses the different management strategies for lesions that put patients at increased risk for breast...

Luminal breast cancer subtypes are characterized by estrogen-receptor and estrogen-related genes, which sets them apart from other tumors that are not hormonally driven.

With estrogen-responsive luminal A and Luminal B metastatic tumors, there is often no distinction in the treatment of disease, which often involves an anti-estrogen. However,...